De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 99, 102254
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trialEuropean Journal of Cancer, 2013
- Local Control, Toxicity, and Cosmesis in Women >70 Years Enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer Patients: A Systematic Review and Meta-analysisJNCI: Journal of the National Cancer Institute, 2011
- 231 Mature results of a randomized trial of tamoxifen with or without breast radiation in women over 50 years of age with T1/2 N0 breast cancerEuropean Journal of Cancer Supplements, 2010
- Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: A prospective randomised multicentre trialThe Breast, 2009
- Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Tamoxifen with or without Breast Irradiation in Women 50 Years of Age or Older with Early Breast CancerNew England Journal of Medicine, 2004
- Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast CancerNew England Journal of Medicine, 2004
- Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or LessJournal of Clinical Oncology, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002